通策医疗
(600763)
| 流通市值：170.26亿 | | | 总市值：170.26亿 |
| 流通股本：3.21亿 | | | 总股本：3.21亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,184,842,620.45 | 1,362,665,563.42 | 674,535,941.41 | 2,718,612,472.58 |
| 营业收入 | 2,184,842,620.45 | 1,362,665,563.42 | 674,535,941.41 | 2,718,612,472.58 |
| 二、营业总成本 | 1,539,579,950.48 | 986,976,026.01 | 459,481,476.7 | 2,029,151,228.17 |
| 营业成本 | 1,254,480,283.64 | 799,134,008.36 | 370,401,513.89 | 1,609,025,036.49 |
| 税金及附加 | 4,608,019.67 | 4,523,118.34 | 242,301.33 | 6,733,325.19 |
| 销售费用 | 20,284,759.04 | 12,060,054.17 | 5,520,369.3 | 28,031,748.86 |
| 管理费用 | 192,634,258.55 | 129,806,020.88 | 66,877,219.72 | 284,777,392.09 |
| 研发费用 | 43,854,031.34 | 27,293,738.23 | 11,077,832.4 | 54,030,766.33 |
| 财务费用 | 23,718,598.24 | 14,159,086.03 | 5,362,240.06 | 46,552,959.21 |
| 其中:利息费用 | 28,418,006.16 | 19,227,626.17 | 9,260,357.41 | 50,046,318.91 |
| 其中:利息收入 | 9,918,485.66 | 8,138,513.69 | 5,454,090.02 | 9,238,998.03 |
| 加:投资收益 | 33,899,780.87 | 22,392,868.81 | 9,093,068.14 | 38,300,685.29 |
| 资产处置收益 | - | - | - | -45,811.56 |
| 信用减值损失(新) | -1,726,984.74 | -1,359,447.06 | -2,326,512.05 | -1,926,100.58 |
| 其他收益 | 6,775,187.48 | 5,077,890.64 | 3,178,807.62 | 8,115,747.44 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 684,210,653.58 | 401,800,849.8 | 224,999,828.42 | 733,905,765 |
| 加:营业外收入 | 514,017.59 | 178,554.71 | 141,992.54 | 6,479,464.76 |
| 减:营业外支出 | 1,638,573.42 | 1,002,144.36 | 402,212.39 | 2,401,494.05 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 683,086,097.75 | 400,977,260.15 | 224,739,608.57 | 737,983,735.71 |
| 减:所得税费用 | 71,063,464.91 | 42,293,149.46 | 27,204,202.43 | 122,305,678.33 |
| 六、净利润 | 612,022,632.84 | 358,684,110.69 | 197,535,406.14 | 615,678,057.38 |
| 持续经营净利润 | 612,022,632.84 | 358,684,110.69 | 197,535,406.14 | 615,678,057.38 |
| 归属于母公司股东的净利润 | 511,732,934.63 | 304,412,526.52 | 168,971,152.17 | 548,269,040.78 |
| 少数股东损益 | 100,289,698.21 | 54,271,584.17 | 28,564,253.97 | 67,409,016.6 |
| (一)基本每股收益 | 1.6 | 0.95 | 0.53 | 1.71 |
| (二)稀释每股收益 | 1.6 | 0.95 | 0.53 | 1.71 |
| 八、其他综合收益 | -3,103,033.22 | -3,103,033.17 | -0.09 | -18,048,078.72 |
| 归属于母公司股东的其他综合收益 | -3,103,033.22 | -3,103,033.17 | -0.09 | -18,048,078.72 |
| 九、综合收益总额 | 608,919,599.62 | 355,581,077.52 | 197,535,406.05 | 597,629,978.66 |
| 归属于母公司股东的综合收益总额 | 508,629,901.41 | 301,309,493.35 | 168,971,152.08 | 530,220,962.06 |
| 归属于少数股东的综合收益总额 | 100,289,698.21 | 54,271,584.17 | 28,564,253.97 | 67,409,016.6 |
| 公告日期 | 2023-10-25 | 2023-08-25 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |